Raymond James Financial Inc Regencell Bioscience Holdings LTD Put Options Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RGC
# of Institutions
13Shares Held
638KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA391KShares$5.26 Million0.0% of portfolio
-
Squarepoint Ops LLC New York, NY99.8KShares$1.34 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY52.1KShares$700,2240.01% of portfolio
-
Ubs Group Ag37.5KShares$504,3620.0% of portfolio
-
Morgan Stanley New York, NY33KShares$443,7880.0% of portfolio
About Regencell Bioscience Holdings Ltd
- Ticker RGC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,012,900
- Market Cap $175M
- Description
- Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated...